New creatinine sensor for point-of-care testing of creatinine meets the National Kidney Disease Education Program guidelines

2008 ◽  
Vol 46 (1) ◽  
Author(s):  
Anne Skurup ◽  
Tina Kristensen ◽  
Gitte Wennecke
Keyword(s):  
Kidney Disease ◽  
Education Program ◽  
Point Of Care ◽  
Point Of Care Testing

Innovative Use of Point-of-Care Testing for Chronic Kidney Disease Screening

2011 ◽  
Vol 10 (2) ◽  
pp. 98-101 ◽  
Author(s):  
Anne K. Shephard ◽  
Mark D.S. Shephard ◽  
Heather J. Halls ◽  
Olivia Corso ◽  
Timothy H. Mathew
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Point Of Care ◽  
Disease Screening ◽  
Point Of Care Testing

scholarly journals Development and validation of point‐of‐care testing of albuminuria for early screening of chronic kidney disease

2021 ◽  
Author(s):  
Nuntanuj Vutthikraivit ◽  
Patcharakorn Kiatamornrak ◽  
Chatikorn Boonkrai ◽  
Trairak Pisitkun ◽  
Kittinan Komolpis ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Point Of Care ◽  
Point Of Care Testing ◽  
Early Screening ◽  
Development And Validation

Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease

2021 ◽  
pp. 193229682110545
Author(s):  
Bernd Schultes ◽  
Susanne Emmerich ◽  
Andreas D. Kistler ◽  
Badreddine Mecheri ◽  
Oliver Schnell ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Kidney Disease ◽  
Glycemic Control ◽  
Diabetic Kidney Disease ◽  
Point Of Care ◽  
Diagnosis And Treatment ◽  
Creatinine Ratio ◽  
Point Of Care Testing ◽  
Treatment Management ◽  
Patients With Diabetes

Background: For the diagnosis of diabetic kidney disease (DKD), quantitative albuminuria measurement using the albumin-to-creatinine ratio (ACR) is recommended according to various guidelines. It can be measured either in specialized laboratories or using ACR point-of-care testing (POCT). This observational study aims at evaluating the effect of ACR POCT utilization on the DKD diagnosis and treatment management for glycemic control and blood pressure. Method: Data of 717 patients with diabetes (type 1 diabetes: n = 236; type 2 diabetes: n = 463; other diabetes forms: n = 18) were assessed in three centers. The impact of ACR POCT on DKD diagnosis and treatment management for glycemic control and blood pressure was assessed using a case report form. The assessment of ACR POCT utilization purpose and relevance for physicians was documented using a questionnaire. Results: Of all participants (n = 717), 39.1% had a confirmed/suspected DKD diagnosis. Hereof, 8.6% were newly diagnosed with DKD, and 9.9% were suspected with DKD based on the actual ACR POCT values. Within the group of patients with confirmed/suspected DKD (n = 280), treatment modification was performed in 46.1% of participants. A drug initiation with GLP-1 receptor agonists or SGLT2 inhibitors was performed in 11.1% or 8.9% of patients with confirmed/suspected DKD, respectively. Regarding the utilization purposes of ACR POCT, 100% of the physicians (n = 8) indicated using it to examine patients with diabetes with or without hypertension; 75% considered it very important for patients with diabetes. Conclusions: The implementation of ACR POCT may positively affect DKD diagnosis and subsequently allow better management of patients with diabetes.

scholarly journals Creatinine point-of-care testing for detection and monitoring of chronic kidney disease: primary care diagnostic technology update

2015 ◽  
Vol 65 (640) ◽  
pp. 608-608 ◽  
Author(s):  
Oghenekome Gbinigie ◽  
Christopher P Price ◽  
Carl Heneghan ◽  
Ann Van den Bruel ◽  
Annette Plüddemann
Keyword(s):  
Primary Care ◽  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Point Of Care ◽  
Point Of Care Testing ◽  
Diagnostic Technology

Magnetic Digital Microfluidics for Point-of-Care Testing: Where Are We Now?

2020 ◽  
Vol 27 ◽  
Author(s):  
Yi Zhang
Keyword(s):  
System Integration ◽  
Diagnostic Tests ◽  
Point Of Care ◽  
Digital Microfluidics ◽  
Controlled Environment ◽  
Point Of Care Testing ◽  
Microfluidic Platforms ◽  
Interface System ◽  
Technical Issues ◽  
Sample System

: Point-of-care (POC) testing decentralizes the diagnostic tests to the sites near the patient. Many POC tests rely microfluidic platforms for sample-to-answer analysis. Compared to other microfluidic systems, magnetic digital microfluidics demonstrate compelling advantages for POC diagnostics. In this review, we have examined the capability of magnetic digital microfluidics-based POC diagnostic platforms. More importantly, we have categorized POC settings into three classes based on “where is the point”, “who to care” and “how to test”, and evaluated the suitability of magnetic digital microfluidics in various POC settings. Furthermore, we have addressed other technical issues associated with POC testing such as controlled environment, sample-system interface, system integration and information connectivity. We hope this review would provide a guideline for the future development of magnetic digital microfluidics-based platforms for POC testing.

Sign in / Sign up

Export Citation Format

Share Document